InvestorPlace - Stock Market News, Stock Advice & Trading Tips
BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
The post BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace